Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2

Por um escritor misterioso

Descrição

Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Malcolm MacCoss's research works Merck & Co., Whitehouse Station (MSD) and other places
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Structural Analysis of Chemokine Receptor-Ligand Interactions. - Abstract - Europe PMC
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Immune regulation by atypical chemokine receptors
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV. - Abstract - Europe PMC
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Pharmaceuticals, Free Full-Text
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Full article: Chemokine receptor antagonists: Part 1
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2 (CCR2) Antagonists
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties - ScienceDirect
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties - ScienceDirect
de por adulto (o preço varia de acordo com o tamanho do grupo)